Lena M Biehl1,2, Rebeca Cruz Aguilar1,2, Fedja Farowski1, Werner Hahn3, Angela Nowag4,5, Hilmar Wisplinghoff4,5,6, Maria J G T Vehreschild7,8. 1. Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany. 2. German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany. 3. Practice for Nephrology and Hypertension, Dialysis, Mayen, Germany. 4. Wisplinghoff Laboratories, Cologne, Germany. 5. Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany. 6. Institute for Virology and Medical Microbiology, Witten/Herdecke University, Witten, Germany. 7. Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany. maria.vehreschild@uk-koeln.de. 8. German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany. maria.vehreschild@uk-koeln.de.
Abstract
PURPOSE: We report on a kidney transplant recipient treated with fecal microbiota transplantation (FMT) for recurrent urinary tract infections. METHODS: FMT was administered via frozen capsulized microbiota. Before and after FMT, urinary, fecal and vaginal microbiota compositions were analyzed. RESULTS: The patient remained without symptoms after FMT. CONCLUSIONS: Underlying mechanisms of action need to be addressed in depth by future research.
PURPOSE: We report on a kidney transplant recipient treated with fecal microbiota transplantation (FMT) for recurrent urinary tract infections. METHODS: FMT was administered via frozen capsulized microbiota. Before and after FMT, urinary, fecal and vaginal microbiota compositions were analyzed. RESULTS: The patient remained without symptoms after FMT. CONCLUSIONS: Underlying mechanisms of action need to be addressed in depth by future research.
Authors: Ann E Stapleton; Melissa Au-Yeung; Thomas M Hooton; David N Fredricks; Pacita L Roberts; Christopher A Czaja; Yuliya Yarova-Yarovaya; Tina Fiedler; Marsha Cox; Walter E Stamm Journal: Clin Infect Dis Date: 2011-04-14 Impact factor: 9.079
Authors: D Tacke; H Wisplinghoff; A Kretzschmar; F Farowski; P Koehler; J Herweg; O A Cornely; M J G T Vehreschild Journal: Clin Microbiol Infect Date: 2015-07-08 Impact factor: 8.067
Authors: Henry L Schreiber; Matt S Conover; Wen-Chi Chou; Michael E Hibbing; Abigail L Manson; Karen W Dodson; Thomas J Hannan; Pacita L Roberts; Ann E Stapleton; Thomas M Hooton; Jonathan Livny; Ashlee M Earl; Scott J Hultgren Journal: Sci Transl Med Date: 2017-03-22 Impact factor: 17.956
Authors: Benjamin J Callahan; Paul J McMurdie; Michael J Rosen; Andrew W Han; Amy Jo A Johnson; Susan P Holmes Journal: Nat Methods Date: 2016-05-23 Impact factor: 28.547
Authors: Casper D J den Heijer; Mariëlle A J Beerepoot; Jan M Prins; Suzanne E Geerlings; Ellen E Stobberingh Journal: PLoS One Date: 2012-11-16 Impact factor: 3.240
Authors: Virginia Perez-Carrasco; Ana Soriano-Lerma; Miguel Soriano; José Gutiérrez-Fernández; Jose A Garcia-Salcedo Journal: Front Cell Infect Microbiol Date: 2021-05-18 Impact factor: 5.293
Authors: Eric C Keen; Preston Tasoff; Tiffany Hink; Kimberly A Reske; Carey-Ann D Burnham; Gautam Dantas; Jennie H Kwon; Erik R Dubberke Journal: Open Forum Infect Dis Date: 2020-02-11 Impact factor: 3.835